Tom Verfaillie

3.8k citations
16 papers · 3.1k indexed · 2 hit papers · h-index 14
Topics
Autophagy in Disease and Therapy (11 papers)Endoplasmic Reticulum Stress and Disease (9 papers)Heme Oxygenase-1 and Carbon Monoxide (3 papers)

In The Last Decade

Tom Verfaillie

16 papers receiving 3.1k citations

Hit Papers

PERK is required at the ER-mitochondrial contact sites to...201220262016202120122012200400600

Peers

Tom Verfaillie
Comparison fields: 5 of 102
  • Molecular Biology 1.5k
  • Cell Biology 1.2k
  • Epidemiology 1.0k
  • Immunology 675
  • Biomedical Engineering 450
Replace Penny E. Lovat with:
Penny E. Lovat United Kingdom
Katherine L. Cook United States
Maria Perander Norway
Dariusz Pytel United States
Yu Jiang United States
Mojgan Djavaheri‐Mergny France
Barbara J. Klocke United States
Kaoru Saegusa Japan
Sze Ham Chan United States
Issam Ben‐Sahra United States
Tom Verfaillie relative to Penny E. Lovat United Kingdom Penny E. Lovat's profile →
Citations per field
00.5×6.6×
Penny E. Lovat · 1×
Citations per year

Countries citing papers authored by Tom Verfaillie

Since Specialization
Citations

This map shows the geographic impact of Tom Verfaillie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Verfaillie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Verfaillie more than expected).

Fields of papers citing papers by Tom Verfaillie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Verfaillie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Verfaillie. The network helps show where Tom Verfaillie may publish in the future.

Co-authorship network of co-authors of Tom Verfaillie

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Verfaillie. A scholar is included among the top collaborators of Tom Verfaillie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Verfaillie. Tom Verfaillie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 167
2 108
3 310
4 62
5 249
6 40
7 21
8
PERK IS REQUIRED AT THE ER-TO-MITOCHONDRIA CONTACT SITES TO CONVEY APOPTOSIS FOLLOWING ROS-MEDIATED ER STRESS
1
9
PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROS-based ER stressbreakdown →
693
10
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell deathbreakdown →
651
11 82
12 19
13 338
14 109
15
Hypericin-PDT treatment of cancer cells leads to surface exposure/extracellular release of DAMPs and activates human immature dendritic cells
3
16 293

About Tom Verfaillie

Tom Verfaillie is a scholar working on Cell Biology, Epidemiology and Geriatrics and Gerontology, having authored 16 papers that have together received 3.1k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (11 papers), Endoplasmic Reticulum Stress and Disease (9 papers) and Heme Oxygenase-1 and Carbon Monoxide (3 papers). The work is most often cited by research in Cell Biology (1.2k citations), Physiology (165 citations) and Immunology (675 citations). Tom Verfaillie has collaborated with scholars based in Belgium, Ireland and United States. Frequent co-authors include Patrizia Agostinis, Abhishek D. Garg, Noemí Rubio, Alexander R. van Vliet, Jacques Piette, Peter Vandenabeele, Dmitri V. Krysko, Afshin Samali, Chantal Mathieu and Gabriela B. Ferreira. Their work appears in journals such as The EMBO Journal, Molecular Cell and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026